Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.84

+2.8%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (22394)	6/17/1998 6:12:00 PM
From: Russian Bear	Read Replies (3) of 32384

Walter and all, <<The BLA was submitted on December 9, 1997, and the complete review letter is dated June 9, 1998.>> I am wondering (1) What could possibly have changed so dramatically within one week of the unanimous positive recommendation regarding ONTAK's safety and efficacy? and (2) Why was the patently material new information regarding the FDA delay not disclosed sooner? My initial reaction is that there is something seriously wrong with Seragen, something which was likely not known to Ligand's management at the time that they inked the deal. RB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next